All content and product details on this site are for educational purposes only. Products are for in-vitro studies (performed outside the body) and not FDA-approved for medical use. Any introduction into humans or animals is prohibited by law.
Categories
Recent Posts
CJC-1295 Peptide Research: GHRH Analog and Growth Hormone
Explore CJC-1295, a GHRH analog originally developed as an investigational compound. Studies have measured its effects on growth hormone and IGF-1 levels.
PP-TS1: GHRH Analog Research
PP-TS1 is a growth hormone-releasing hormone analog studied for its stability, GHRH-receptor pharmacology and GH/IGF-1 responses. A summary of the published literature.
Peptides and Aging Biology: A Research Overview
Peptides are gaining attention as research tools in aging biology. These short chains of amino acids regulate cellular repair, inflammation, and hormonal balance, processes that are studied in research on age-related conditions. Recent research has examined their interactions with aging mechanisms. This article explores peptides’ role in aging biology research and the challenges facing this field.
Adamax Peptide: A Nootropic Peptide Option?
Brief Overview/Summary
Explore research on Adamax peptide, a modified form of Semax, and published Semax studies on BDNF signalling and neuronal function
The peptide known as ADAMAX has been receiving interest in the field of nootropic peptide research. Adamax is a modified version of SEMAX, a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) related to the adrenocorticotropic hormone fragment ACTH(4–10) [1]. Much of the published Semax literature comes from research groups at the Institute of Molecular Genetics of the Russian Academy of Sciences [1][2].
ADAMAX is a research compound in which the Semax sequence is acetylated at the N-terminus and carries an adamantylated glycine at the C-terminus. The same kind of C-terminal adamantyl-glycine modification was used by another research group on a CNTF-derived peptide (P021) to increase lipophilicity and to decrease degradation by exopeptidases [3][4]. As a result of this modification, ADAMAX differs structurally from Semax. No peer-reviewed studies of Adamax itself were identified at the time of writing, so the research summarised below concerns Semax, and whether these findings apply to Adamax has not been established.
Mechanism of Action of Adamax Peptide
The synthetic peptide Semax, from which Adamax is derived, is an analogue of ACTH(4–10) [1]. Its sequence consists of the ACTH(4–7) fragment (Met-Glu-His-Phe) followed by the tripeptide Pro-Gly-Pro [5]. In rodent studies it has been associated with effects on learning and with neuroprotective activity, and most mechanistic work has focused on brain-derived neurotrophic factor (BDNF), a neurotrophic factor involved in synaptic plasticity and neuronal survival [1][6].
In the rat hippocampus, a single exposure to Semax increased BDNF protein levels, the tyrosine phosphorylation of its receptor, tropomyosin receptor kinase B (TrkB), and the mRNA levels of both BDNF and TrkB [1]. In membranes from the rat basal forebrain, labelled Semax showed specific, calcium-dependent binding, and Semax increased BDNF protein levels in that brain region [6]. The authors suggested that the hippocampal BDNF/TrkB system may be one route by which Semax affects cognitive measures in rats [1].
In vitro, Semax and the related heptapeptide Selank inhibited enzymes in human serum that degrade enkephalins and other regulatory peptides, and their pentapeptide fragments shared this activity [7]. The authors proposed that this inhibition of peptide-degrading enzymes may be one of the mechanisms behind the peptides' biological activity [7].
Semax also has a high affinity for copper(II) ions. In artificial membrane models, Semax prevented the formation of complexes between amyloid beta (Aβ) and Cu2+ and showed anti-aggregating activity, especially in the presence of copper [8]. In vitro, it extracted Cu(II) from Cu(II)–Aβ species, decreased the associated production of reactive oxygen species and protected SH-SY5Y cells against oxidative stress induced by copper-catalysed oxidation of Aβ [9].
Whether Adamax shares these properties is not known: no peer-reviewed data describe its receptor binding, its interaction with copper or its stability in biological systems.
Research Evidence of Adamax Peptide
Because studies on Adamax have not been published in the peer-reviewed literature, the available evidence for this peptide family comes from Semax research. In a rat model of focal cerebral ischemia, a genome-wide transcriptional analysis found that Semax predominantly enhanced the expression of genes related to the immune system and altered the expression of genes related to the vascular system [2].
A later transcriptome study in rats with focal cerebral ischemia reported that Semax enhanced antigen-presentation signalling and affected immunoglobulin, cytokine and stress-response genes, while the Pro-Gly-Pro tripeptide alone had different effects [5]. In a rat model of cerebral ischemia–reperfusion, protein expression profiling showed upregulation of active CREB and downregulation of MMP-9, c-Fos and active JNK in specific brain regions after Semax exposure [10].
Research Application of Adamax Peptide
Semax is studied in neuroscience research because of its reported effects on the BDNF/TrkB system and on gene and protein expression in rat models of brain ischemia [1][2][10]. These studies use animal models together with molecular methods such as transcriptome and protein expression profiling [2][5][10].
A second line of research concerns Semax's interaction with copper ions and amyloid beta, studied with spectrofluorometric, calorimetric and cell-viability assays in membrane models and neuronal cell lines [8][9].
Comparative pharmacology has examined Semax alongside the related synthetic heptapeptide Selank, for example in assays of enkephalin-degrading enzymes, where Semax showed the more potent inhibition [7]. The relative activity of Adamax in these systems has not been established.
Structural modification is a recurring theme in this field. Adamantane-containing peptides were designed to increase lipophilicity and resistance to exopeptidases [3][4], and Adamax applies a similar idea to the Semax sequence. Its properties in laboratory models remain to be characterised.
Future Research Perspective of Adamax Peptide
Ongoing research on Semax continues to investigate its effects on neurotrophic signalling and on gene and protein expression in rat models of cerebral ischemia [1][2][5][10].
For Adamax, the first research questions are basic ones. Clarifying its stability, receptor binding and interaction with BDNF signalling is one area of research that could show how it differs from Semax. Its behaviour in the copper and amyloid-beta assays used for Semax [8][9] is another open question.
Structural modification studies seek to increase the resistance of peptides to enzymatic degradation, as with the adamantane-modified peptides described above [3]. These lines of inquiry may deepen understanding of peptide-based research compounds and clarify the role of Adamax and Semax in neuroscience research.
References
Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, et al. (2006). Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 1117(1), 54–60. https://doi.org/10.1016/j.brainres.2006.07.108
Medvedeva EV, Dmitrieva VG, Povarova OV, Limborska SA, Skvortsova VI, Myasoedov NF, Dergunova LV. (2014). The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics, 15, 228. https://doi.org/10.1186/1471-2164-15-228
Li B, Wanka L, Blanchard J, Liu F, Chohan MO, Iqbal K, Grundke-Iqbal I. (2010). Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice. FEBS Letters, 584(15), 3359–3365. https://doi.org/10.1016/j.febslet.2010.06.025
Baazaoui N, Iqbal K. (2017). Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound. Alzheimer's Research & Therapy, 9(1), 45. https://doi.org/10.1186/s13195-017-0273-7
Medvedeva EV, Dmitrieva VG, Limborska SA, Myasoedov NF, Dergunova LV. (2017). Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats. Molecular Genetics and Genomics, 292(3), 635–653. https://doi.org/10.1007/s00438-017-1297-1
Dolotov OV, Karpenko EA, Seredenina TS, Inozemtseva LS, Levitskaya NG, Zolotarev YA, et al. (2006). Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. Journal of Neurochemistry, 97(Suppl 1), 82–86. https://doi.org/10.1111/j.1471-4159.2006.03658.x
Kost NV, Sokolov OY, Gabaeva MV, Grivennikov IA, Andreeva LA, Myasoedov NF, Zozulya AA. (2001). Semax and Selank Inhibit the Enkephalin-Degrading Enzymes of Human Serum. Russian Journal of Bioorganic Chemistry, 27(3), 156–159. https://doi.org/10.1023/a:1011373002885
Sciacca MFM, Naletova I, Giuffrida ML, Attanasio F. (2022). Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models. ACS Chemical Neuroscience, 13(4), 486–496. https://doi.org/10.1021/acschemneuro.1c00707
Tomasello MF, Di Rosa MC, Naletova I, Sciacca MFM, Giuffrida A, Maccarrone G, Attanasio F. (2025). Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing. Bioinorganic Chemistry and Applications, 2025, 4226220. https://doi.org/10.1155/bca/4226220
Sudarkina OY, Filippenkov IB, Stavchansky VV, Denisova AE, Yuzhakov VV, Sevan'kaeva LE, et al. (2021). Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion. International Journal of Molecular Sciences, 22(12), 6179. https://doi.org/10.3390/ijms22126179
Read more about peptides
Sermorelin Peptide: Growth Hormone Secretion Research
Explore research on Sermorelin peptide, its role in growth hormone secretion and pituitary function through scientific studies
BPC-157 and TB-500: Musculoskeletal Repair Research
Published research on BPC-157 and TB-500, covering their studied roles in tissue repair, cell migration and musculoskeletal recovery models.